Aioptics
1 known investors
AI Optics builds handheld eye-imaging hardware (the FDA-cleared Sentinel Camera) and AI-based screening software (Sentinel Pro) to detect retinal diseases such as diabetic retinopathy, age-related macular degeneration, and glaucoma at the point of care. The products are aimed at expanding access to specialist-level diagnostic screening in the medical/ophthalmic diagnostics field.